Not Yet Recruiting
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
- Locations
-
- First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China